RHOADS ANN D 4

What Happened

• Ann D. Rhoads, a director of Globus Medical, was granted 15,000 derivative awards (recorded as acquisition at $0.00) on January 21, 2026. The filing classifies this as an award/grant (code A); no immediate cash value or exercised shares are reported in this Form 4.

Key Details

• Transaction date: 2026-01-21 (Filed: 2026-01-23) — filing appears timely.
• Transaction type/code: Grant / Award (A); recorded acquisition price $0.00.
• Quantity: 15,000 derivative securities (options/awards).
• Vesting: These options were granted Jan 21, 2026 and will vest on Jan 1, 2027 (footnote F1).
• Shares owned after transaction: Not specified in the provided Form 4.
• Notable: The filing does not disclose strike/exercise price or immediate market value; no sale or exercise occurred.

Context

• This is a grant of derivative awards (options) to a director — not a sale. Such awards typically vest over time and must usually be exercised to convert into company stock; until vesting/exercise they do not represent tradable shares.
• Investors seeking valuation details should look to proxy statements, company disclosures, or subsequent filings for strike price, expiration, and total potential value.